NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES (Note: All dollar amounts in this news release are expressed in U.S. dollars, except as otherwise noted).
License provides Lisata’s innovative certepetide targeting agent for use with Kuva’s NanoMark™ MR imaging platform to advance non-invasive, high-precision cancer diagnosticsBASKING RIDGE, N.J. and ...
Putin not interested in peace ahead of crucial winter, says Nato boss in stark warning - It comes as Germany and the United States unveiled more than £1bn in military aid for Ukraine ...